The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex

DOI: 10.1080/2162402X.2018.1532764

Keywords: ALT-803, N-803, IL-15, N-809, anti-PD-L1, immunotherapy, checkpoint inhibitor, cytokine, carcinoma, ADCC

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text